ENDRA Life Sciences (NDRA) EBT Margin (2016 - 2018)

ENDRA Life Sciences (NDRA) has 3 years of EBT Margin data on file, last reported at 45761.31% in Q1 2018.

• EBT Margin for Q1 2018 came in at 45761.31%, changed N/A year-over-year; the trailing twelve-month figure through Dec 2018 was 158669.6% (down 15714041.0% YoY), and the FY2018 annual result was 158669.6%, down 15714041.0% from the prior year.
• EBT Margin declined to 45761.31% in Q1 2018 per NDRA's latest filing, from 33498.39% in the prior quarter.
• Over five years, EBT Margin peaked at 133.61% in Q4 2016 and troughed at 45761.31% in Q1 2018.
• A 3-year average of 16437.67% and a median of 2478.35% in 2017 frame the typical range for EBT Margin.
• On a YoY basis, EBT Margin climbed as much as 3336478 bps in 2017 and fell as far as 3336478 bps in 2017.
• A 3-year view of EBT Margin shows it stood at 133.61% in 2016, then tumbled by 24971 bps to 33498.39% in 2017, then tumbled by 37 bps to 45761.31% in 2018.
• Business Quant data shows NDRA's EBT Margin at 45761.31% in Q1 2018, 33498.39% in Q4 2017, and 316.69% in Q3 2017.